Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
#Poc Hba1C Testing Market Revenue Growth On Track For A 11.4% CAGR Through 2030#_x000D_
The poc hba1c testing market has shown considerable growth in recent years. Its size is expected to increase from $1.02 billion in 2025 to $1.14 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.9%. Historically, this growth has been fueled by the rising global prevalence of diabetes, increased clinical reliance on long-term glucose monitoring, the expansion of outpatient diagnostic services, growing awareness of early diabetes diagnosis, and the availability of compact diagnostic instruments._x000D_
_x000D_
The poc hba1c testing market is anticipated to experience significant expansion in the coming years. This market is projected to reach $1.76 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.4%. This growth during the forecast period is attributable to several factors, including the rising adoption of decentralized diagnostics, an escalating demand for home care testing solutions, the broadening of digital diabetes management programs, a heightened emphasis on preventive healthcare, and increased investments in rapid diagnostic technologies. Key trends anticipated during the forecast period involve the wider adoption of rapid point-of-care hba1c devices, an increase in the utilization of portable and handheld testing systems, a surge in demand for home-based diabetes monitoring, the expansion of integrated poc diagnostic platforms, and an elevated focus on test accuracy and standardization._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Poc Hba1C Testing Market Growth Factors: What’s Supporting Expansion?#_x000D_
The rising incidence of diabetes is propelling the expansion of the point-of-care (POC) HbA1C testing market. Diabetes, a persistent metabolic condition, is defined by elevated blood glucose levels and necessitates continuous monitoring to prevent severe outcomes such as neuropathy, cardiovascular disease, and renal impairment. This escalation in diabetes diagnoses globally stems from factors like sedentary lifestyles, unhealthy dietary patterns, obesity, and the aging of populations. The growing prevalence of diabetes actively supports the POC HbA1C testing market by escalating the demand for rapid, convenient, and accurate assessments of glycemic control across clinics, pharmacies, and home-care settings, thereby facilitating prompt treatment interventions. To illustrate, in 2025, according to the International Diabetes Federation, a Belgium-based health organization, in 2024, around 589 million adults aged 20-79 were living with diabetes, with the total number projected to reach 853 million by 2050 and with more than 4 in 5 adults with diabetes residing in low and middle income countries. Consequently, the increasing prevalence of diabetes is a primary driver for the growth of the POC hba1c testing market._x000D_
_x000D_
#Poc Hba1C Testing Market Segments: Where Is Growth Concentrated?#_x000D_
The poc hba1c testing market covered in this report is segmented – _x000D_
_x000D_
1) By Type of Product: Instruments, Consumables_x000D_
2) By Technology: Ion-Exchange HPLC, Enzymatic Assay, Affinity Binding Chromatography, Immunoassay, Other Technologies_x000D_
3) By End User: Hospitals, Physician Office Or Outpatient Center, Home Care, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Instruments: Handheld HbA1c Testing Devices, Portable HbA1c Analyzers, Desktop HbA1c Testing Systems, Integrated Point Of Care Testing Systems _x000D_
2) By Consumables: Test Strips, Control Solutions, Reagents, Calibration Solutions, Sample Collection Devices _x000D_
_x000D_
#Poc Hba1C Testing Market Industry Trends: What’s Reshaping Demand?#_x000D_
Leading companies in the point-of-care (POC) HbA1c testing market are progressively incorporating integrated internal verification mechanisms. This aims to guarantee test accuracy, minimize error potential, and enhance confidence in diagnostics performed close to the patient. Such automated checking systems continually observe ambient conditions, the intactness of samples, and the performance of assays during every test, thereby preventing incorrect outcomes or the spoilage of samples. An example is Siemens Healthineers, a Germany-based company specializing in medical technology, which introduced its next-generation point-of-care Atellica DCA Analyser in July 2024. The Atellica DCA Analyzer utilizes its exclusive Auto-Checks Technology. This technology performs a comprehensive set of internal calibrations and validations during the entire testing procedure, encompassing environmental calibration, verification of airflow and temperature, assessment of sample volume and integrity, optical clarity, and precision checks. This automated self-monitoring system guarantees that each HbA1c result, provided in merely 4–5 minutes, possesses laboratory-grade quality, simultaneously lessening the requirement for continuous oversight from an operator. By incorporating these inherent self-checks, the Atellica DCA aids in reducing pre-analytical mistakes, improving the reliability of results, and facilitating the expansion of point of care (POC) testing, especially in environments with constrained laboratory infrastructure._x000D_
_x000D_
#Poc Hba1C Testing Market Leading Players And Competitive Positioning#_x000D_
Major companies operating in the poc hba1c testing market are F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Bio-Rad Laboratories Inc, Menarini Group, Danaher Corporation, Tosoh Bioscience Inc, ARKRAY Inc, i-SENS Inc, Abbott Laboratories, Trinity Biotech plc, Aina Blood Monitoring System, Getein Biotech Inc, Sugentech Inc, Alere Inc, EKF Diagnostics, HemoCue, PTS Diagnostics, Osang Healthcare, Ortho Clinical Diagnostics, Ascensia, Platinum Equity (LifeScan), Becton Dickinson and Company, Kainico Ltd, Evia Medical Technologies, Agamatrix Inc, Bionime Corporation _x000D_
_x000D_
#View The Full Poc Hba1C Testing Market Report:#_x000D_
_x000D_
#Poc Hba1C Testing Market Regional Split: Which Areas Are Fueling Growth?#_x000D_
North America was the largest region in the POC HbA1C testing market in 2025. Africa is expected to be the fastest-growing region in the forecast- period. The regions covered in the poc hba1c testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.